Schmid Summarizes Updates in HER2-Positive Breast Cancer Management

Season 10 Episode 24  ·  Apr 01, 2024, 06:50 PM

Headliner
Share
Subscribe

Dr Schmid discusses considerations for applying recent data updates in HER2-positive breast cancer management to clinical practice.

Share
Subscribe
Next
FDA Approval Insights: Ponatinib in Ph+ ALL
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air